Jonathan Edwards: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(removed citation needed tag) |
(added citation; converted citation; reordered sections) |
||
| Line 3: | Line 3: | ||
==B-cell depletion ME/CFS research== | ==B-cell depletion ME/CFS research== | ||
Professor Edwards became interested in the possible use of [[Rituximab]] to treat [[ME/CFS]] after attending the [[Invest in ME International ME Conference]] in May 2013 and subsequently agreed to advise on and lead the effort. | Professor Edwards became interested in the possible use of [[Rituximab]] to treat [[ME/CFS]] after attending the [[Invest in ME International ME Conference]] in May 2013 and subsequently agreed to advise on and lead the effort.<ref>{{Cite web|url=https://forums.phoenixrising.me/threads/interview-professor-jonathan-edwards-on-the-uk-rituximab-trial.25070/|title=Interview: Professor Jonathan Edwards on the UK Rituximab trial|website=Phoenix Rising ME / CFS Forums|language=en-US|access-date=2019-12-04}}</ref> | ||
==Committees and boards== | ==Committees and boards== | ||
| Line 20: | Line 20: | ||
==Publications related to ME/CFS== | ==Publications related to ME/CFS== | ||
*2016, The biological challenge of [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]: a solvable problem, Editorial by Jonathan C.W. Edwards, [[Simon McGrath]], Adrian Baldwin, Mark Livingstone & Andrew Kewley<ref>Edwards | *2016, The biological challenge of [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]: a solvable problem, Editorial by Jonathan C.W. Edwards, [[Simon McGrath]], Adrian Baldwin, Mark Livingstone & Andrew Kewley<ref>{{Cite journal|last=Edwards|first=Jonathan C.W.|author-link=Jonathan Edwards|last2=McGrath|first2=Simon|author-link2=Simon McGrath|last3=Baldwin|first3=Adrian|author-link3=|last4=Livingstone|first4=Mark|author-link4=|last5=Kewley|first5=Andrew|author-link5=|last6=|first6=|author-link6=|last7=|first7=|last8=|first8=|date=2016-04-02|title=The biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problem|url=http://www.tandfonline.com/doi/full/10.1080/21641846.2016.1160598|journal=Fatigue: Biomedicine, Health & Behavior|language=en|volume=4|issue=2|pages=63–69|doi=10.1080/21641846.2016.1160598|issn=2164-1846|pmc=4867862|pmid=27226928|access-date=|quote=|via=}}</ref> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2016.1160598 (Full Text)] | ||
*2017, [[PACE Trial Management Group|PACE team]] response shows a disregard for the principles of science in ''Journal of Health Psychology''<ref>{{Cite web|url=http://journals.sagepub.com/doi/full/10.1177/1359105317700886|title=PACE team response shows a disregard for the principles of science|last=Edwards|first=Jonathan Edwards|date=Mar 28, 2017|website=journals.sage.pub|publisher=Journal of Health Psychology|archive-url=|archive-date=|dead-url=|access-date=}}</ref> [http://journals.sagepub.com/doi/full/10.1177/1359105317700886 (Full Text)] | *2017, [[PACE Trial Management Group|PACE team]] response shows a disregard for the principles of science in ''Journal of Health Psychology''<ref>{{Cite web|url=http://journals.sagepub.com/doi/full/10.1177/1359105317700886|title=PACE team response shows a disregard for the principles of science|last=Edwards|first=Jonathan Edwards|date=Mar 28, 2017|website=journals.sage.pub|publisher=Journal of Health Psychology|archive-url=|archive-date=|dead-url=|access-date=}}</ref> - [http://journals.sagepub.com/doi/full/10.1177/1359105317700886 (Full Text)] | ||
==Talks and interviews== | ==Talks and interviews== | ||
| Line 27: | Line 27: | ||
*May 30, 2014, Keynote Speaker at the 9th [[Invest in ME International ME Conference]] - [http://www.investinme.eu/IIMEC9.shtml#dvd DVD available]<ref>{{Cite web|url=http://www.investinme.eu/IIMEC9.shtml#dvd|title=IIMEC9 Conference DVD|last=|first=|date=|website=IIMEC9|archive-url=|archive-date=|dead-url=|access-date=}}</ref> | *May 30, 2014, Keynote Speaker at the 9th [[Invest in ME International ME Conference]] - [http://www.investinme.eu/IIMEC9.shtml#dvd DVD available]<ref>{{Cite web|url=http://www.investinme.eu/IIMEC9.shtml#dvd|title=IIMEC9 Conference DVD|last=|first=|date=|website=IIMEC9|archive-url=|archive-date=|dead-url=|access-date=}}</ref> | ||
==See also== | ==See also== | ||
| Line 37: | Line 34: | ||
*[[Rituximab]] | *[[Rituximab]] | ||
== Learn more == | |||
* Jul 20, 2018, [https://www.meassociation.org.uk/wp-content/uploads/Dear-Professor-Watt-Jo-Edwards-MRC-PACE-Trial-July-2018.pdf Letter to Professor Fiona Watt]<ref>{{Cite web|url=https://www.meassociation.org.uk/wp-content/uploads/Dear-Professor-Watt-Jo-Edwards-MRC-PACE-Trial-July-2018.pdf|title=Letter to Professor Watt|last=Edwards|first=Jonathan|date=Jul 20, 2018|website=meassociation.com|archive-url=|archive-date=|dead-url=|access-date=}}</ref> | |||
==References== | ==References== | ||
<references /> | <references /> | ||
Revision as of 01:48, December 4, 2019
Professor Jonathan Edwards is an Emeritus Professor of Connective Tissue Medicine at University College London (UCL) in the UK. Professor Edwards was instrumental in the discovery of the use of B-cell depletion therapy (Rituximab) to treat rheumatoid arthritis.[1]
B-cell depletion ME/CFS research[edit | edit source]
Professor Edwards became interested in the possible use of Rituximab to treat ME/CFS after attending the Invest in ME International ME Conference in May 2013 and subsequently agreed to advise on and lead the effort.[2]
Committees and boards[edit | edit source]
Phoenix Rising[edit | edit source]
Professor Edwards once served on the board of directors of the online patient community Phoenix Rising.[3]
Science for ME[edit | edit source]
Professor Edwards is currently active on the Science for ME forum. [4]
Advocacy[edit | edit source]
Open Letters to The Lancet[edit | edit source]
In response to The Lancet's publication of the controversial PACE trial in 2011, three open letters to the editor of The Lancet urged the editor, Richard Horton, to commission a fully independent review of the PACE trial. Dr. Edwards signed all three. The first, written in 2015, was signed by Dr. Edwards and five of his colleagues. In 2016, thirty-six additional colleagues in the ME/CFS field, signed the second letter. In 2018, a resubmitted letter had over one hundred signatories.
- Nov 13, 2015, An open letter to Dr. Richard Horton and The Lancet[5]
- Feb 10, 2016, An open letter to The Lancet, again - Virology blog[6]
- Jul 9, 2018, Yet Another Appeal to The Lancet, With More On Board[7]
[edit | edit source]
- 2016, The biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problem, Editorial by Jonathan C.W. Edwards, Simon McGrath, Adrian Baldwin, Mark Livingstone & Andrew Kewley[8] - (Full Text)
- 2017, PACE team response shows a disregard for the principles of science in Journal of Health Psychology[9] - (Full Text)
Talks and interviews[edit | edit source]
- May 30, 2014, Keynote Speaker at the 9th Invest in ME International ME Conference - DVD available[11]
See also[edit | edit source]
Learn more[edit | edit source]
- Jul 20, 2018, Letter to Professor Fiona Watt[12]
References[edit | edit source]
- ↑ "B cell depletion: an effective therapy in rheumatoid arthritis". www.ucl.ac.uk. Retrieved August 30, 2018.
- ↑ "Interview: Professor Jonathan Edwards on the UK Rituximab trial". Phoenix Rising ME / CFS Forums. Retrieved December 4, 2019.
- ↑ "Phoenix Rising Adds Two New Board Members". Phoenix Rising. October 6, 2014. Retrieved August 30, 2018. Cite has empty unknown parameter:
|dead-url=(help) - ↑ Edwards, Jonathan. "Science for ME Profile Page". s4me.info. Cite has empty unknown parameter:
|dead-url=(help) - ↑ Tuller, David (November 13, 2015). "An open letter to Dr. Richard Horton and The Lancet". Virology Blog. Cite has empty unknown parameter:
|dead-url=(help) - ↑ Tuller, David (February 10, 2016). "An open letter to The Lancet, again". Virology Blog. Cite has empty unknown parameter:
|dead-url=(help) - ↑ Tuller, David (July 10, 2018). "Trial By Error: Yet Another Appeal to The Lancet, With More On Board". Virology Blog. Cite has empty unknown parameter:
|dead-url=(help) - ↑ Edwards, Jonathan C.W.; McGrath, Simon; Baldwin, Adrian; Livingstone, Mark; Kewley, Andrew (April 2, 2016). "The biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problem". Fatigue: Biomedicine, Health & Behavior. 4 (2): 63–69. doi:10.1080/21641846.2016.1160598. ISSN 2164-1846. PMC 4867862. PMID 27226928.
- ↑ Edwards, Jonathan Edwards (March 28, 2017). "PACE team response shows a disregard for the principles of science". journals.sage.pub. Journal of Health Psychology. Cite has empty unknown parameter:
|dead-url=(help) - ↑ "Interview: Professor Jonathan Edwards on the UK Rituximab trial". Phoenix Rising. September 3, 2013. Cite has empty unknown parameter:
|dead-url=(help) - ↑ "IIMEC9 Conference DVD". IIMEC9. Cite has empty unknown parameter:
|dead-url=(help) - ↑ Edwards, Jonathan (July 20, 2018). "Letter to Professor Watt" (PDF). meassociation.com. Cite has empty unknown parameter:
|dead-url=(help)
